Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Paula Abreu, PhD

Pfizer Inc

Disclosure(s): Pfizer Inc: Employee, Stocks/Bonds

Poster(s):

1156 - Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET